| PERIOD ENDING |
30-Oct-09 |
31-Jul-09 |
24-Apr-09 |
23-Jan-09 |
| Total Revenue |
3,838,000 |
3,933,000 |
3,829,000 |
3,494,000 |
| Cost of Revenue |
922,000 |
966,000 |
932,000 |
848,000 |
|
| Gross Profit |
2,916,000 |
2,967,000 |
2,897,000 |
2,646,000 |
|
| Operating Expenses |
| Research Development |
369,000 |
370,000 |
368,000 |
337,000 |
| Selling General and Administrative |
1,547,000 |
1,368,000 |
970,000 |
1,601,000 |
| Non Recurring |
(166,000) |
602,000 |
1,103,000 |
72,000 |
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss |
1,166,000 |
627,000 |
456,000 |
636,000 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
38,000 |
(356,000) |
348,000 |
| Earnings Before Interest And Taxes |
1,007,000 |
665,000 |
100,000 |
984,000 |
| Interest Expense |
(104,000) |
104,000 |
52,000 |
52,000 |
| Income Before Tax |
1,111,000 |
561,000 |
48,000 |
932,000 |
| Income Tax Expense |
242,000 |
116,000 |
(80,000) |
209,000 |
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops |
869,000 |
445,000 |
128,000 |
723,000 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
869,000 |
445,000 |
128,000 |
723,000 |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares |
$869,000 |
$445,000 |
$128,000 |
$723,000 |
|